Multiparametric MRI-ultrasound fusion prostate biopsy in patients without prior diagnosis of prostate cancer: beyond centers of excellence.
Sadhna VermaJoseph ZegarConnor G HogeJohn McGreadyAbhinav SidanaPublished in: The aging male : the official journal of the International Society for the Study of the Aging Male (2021)
FBx detects a higher proportion of clinically significant disease and a lower proportion of clinically insignificant disease compared to SBx, in line with outcomes demonstrated by centers of excellence.
Keyphrases
- prostate cancer
- end stage renal disease
- magnetic resonance imaging
- newly diagnosed
- chronic kidney disease
- ejection fraction
- radical prostatectomy
- peritoneal dialysis
- prognostic factors
- ultrasound guided
- computed tomography
- magnetic resonance
- diffusion weighted imaging
- adipose tissue
- metabolic syndrome
- fine needle aspiration
- patient reported
- benign prostatic hyperplasia